摘要
肺神经内分泌肿瘤是常见的神经内分泌肿瘤,起源于前肠,肺神经内分泌肿瘤发病率为1.35/10万。肺神经内分泌肿瘤是一个独特的肺肿瘤亚群,占所有神经内分泌肿瘤的25%,近年来发病率的快速增加,主要原因是随着病理诊断方法的改进,对该疾病的认识不断提高。
出处
《实用肿瘤杂志》
CAS
2014年第5期412-416,共5页
Journal of Practical Oncology
基金
浙江省卫生厅项目(N20090540)
同被引文献27
-
1Yao JC, Hassan M, Phan A,et al. One hundred years after " carcinoid" : epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States [ J 1- J Clin Oncol, 2008,26 ( 18 ) :3063 - 3072.
-
2Lepage C, Ciccolallo L, De Angelis R,et al. European dis- parities in malignant digestive endocrine tumours survival [J]. Int J Cancer,2010,126(12) :2928 -2934.
-
3Sorbye H, Welin S, Langer SW, et al. Predictive and prog- nostic factors for treatment anti survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma ( WHO G3 ) : the NORDIC NEC study [ J ] Ann Oncol, 2013,24(1) :152 - 160.
-
4Brenner B,Tang LH, Klimstra DS, et al. Small-cell carci- nomas of the gastrointestinal tract: a review [ J ]J Clin Oncol, 2004,22 ( 13 ) : 2730 - 2739.
-
5Sorbye H, Strosberg J, Baudin E, et al. Gastroenteropan- creatic high-grade neuroendocrine carcinoma[J] Cancer, 2014,120(18) :2814 -2823.
-
6Yamaguchi T, Machida N, Morizane C, et al. Multicenter retrospective analysis of systemic chemotherapy for ad- vanced neuroendocrine carcinoma of the digestive system [J]. Cancer Sci,2014,105(9) :1176 -1181.
-
7Noda K, Nishiwaki Y, Kawahara M, et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for exten- sive small-cell lung cancer[J]. N Engl J Med,2002,346 (2) :85 -91.
-
8Yamaguehi T, Machida N, Morizane C, et al. Multicenter retrospective analysis of systemic chemotherapy for ad- vanced neuroendoerine carcinoma of the digestive system [J]. Cancer Sci,2014,105:1176 - 1181.
-
9Hentic O, Hammel P, Couvelard A, et al. FOLFIRI regi- men: an effective second-line chemotherapy after failure of etoposide-platinum combination in patients with neu- roendoerine carcinomas grade 3 [ J]. Endocr Relat Cane- er,2012,19(6) :751 -757.
-
10Gareia-Carbonero R, Sorbye H, Baudin E, et al. ENETS consensus guidelines for high-grade gastroenteropancre- atic neuroendocrine tumors and neuroendocrine carcino- mas [ J 1. Neuroendoerinology, 2016,103 ( 2 ) : 186 - 194.
引证文献2
-
1赵晓莹,张文,尹海庆,胡健,王辰辰,朱晓东,郭伟剑,陈治宇.FOLFIRI方案联合或不联合贝伐珠单抗治疗转移性GEP-NEC的疗效和安全性[J].实用肿瘤杂志,2016,31(5):462-468. 被引量：4
-
2莫艳芳.中医治疗肺神经内分泌癌1例体会[J].TMR经典中医研究,2018,1(1):18-22.
二级引证文献4
-
1裴效瑞,张权,卢德宝.胃肠道神经内分泌肿瘤患者的药物治疗进展[J].医疗装备,2018,31(21):202-204. 被引量：1
-
2王海增,陈红娜,宋太民.神经内分泌瘤肝转移患者MSCT表现及TACE术联合化疗治疗效果分析[J].中国CT和MRI杂志,2018,16(10):93-96.
-
3李碧湘,张小琴,郑凯.健脾解毒汤联合化疗治疗胃癌疗效及安全性研究[J].中华中医药学刊,2019,37(12):2833-2836. 被引量：15
-
4高靓,何蕊.国内贝伐珠单抗超说明书用药现状及分析[J].药品评价,2022,19(17):1084-1088. 被引量：4
-
1张文玉,黄勇,申洪明,李文武.肺神经内分泌肿瘤的临床病理特征及影像学诊断[J].实用肿瘤杂志,2012,27(1):101-104. 被引量：15
-
2聂敏,陈晨,辛华,王涛.肺神经内分泌肿瘤的CT表现[J].医学影像学杂志,2015,25(10):1785-1787. 被引量：4
-
3王江辉,陈忠年,王啸湘,徐元鼎.肺神经内分泌肿瘤的图象分析[J].上海医科大学学报,1992,19(4):285-288. 被引量：1
-
4何亚奇,唐秉航,孙世珺,吴任国,李良才.肺神经内分泌肿瘤的CT诊断与病理对照[J].临床放射学杂志,2013,32(9):1263-1267. 被引量：8
-
5梁超群,毛晓燕,刘晖,孟云霄,丛林.肺神经内分泌肿瘤的临床病理学分析[J].实用肿瘤学杂志,2006,20(2):125-126. 被引量：3
-
6田燕雏,葛炳生,张波,罗杰,张晶,赵恭华,李廷,赵凤瑞.pRB、E_2F_1在肺神经内分泌肿瘤中的表达及其临床意义[J].中华医学杂志,2001,81(4):219-221. 被引量：7
-
7胡秋芳,杨小东,张娟,黄燕花,吴立雪.肺微瘤型类癌10例临床特征分析及文献复习[J].重庆医学,2014,43(36):4909-4913. 被引量：1
-
8刘由军,黄华福,尹生江,黄晓蓉,姜聪明.肺神经内分泌肿瘤临床表现及CT诊断[J].实用放射学杂志,2008,24(1):131-132. 被引量：8
-
9肺神经内分泌肿瘤综述[J].中华医学信息导报,2008,23(7):14-14.
-
10朱锋锋,高文,陈昶.肺类癌外科治疗的疗效分析[J].中华外科杂志,2009,47(2):152-153. 被引量：1
